Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (251-260 of 544) with videos related to

Pageof 55
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 2011
Optimizing Canadian public immunization programs: a prescription for actionDavid W Scheifele, Monika Naus, Natasha S Crowcroft, et al.
Vaccine|November 4, 2015
Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workersBrenda L Coleman, Shelly A McNeil, Joanne M Langley, et al.
Vaccine|December 17, 2005
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of ageDavid W Scheifele, Scott A Halperin, Bruce Smith, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2020
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age NewbornsDongDong Ma, Miguel Angel Luque-Fernandez, Delia Bogdanet, et al.
The Pediatric Infectious Disease Journal|December 24, 2005
A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trialDavid W Scheifele, Scott A Halperin, Jan J Ochnio, et al.
The Pediatric Infectious Disease Journal|January 2, 2007
Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yetScott A Halperin, Wendy Vaudry, Francois D Boucher, et al.
Molecular Immunology|March 13, 2009
Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factorMatthew L Mayer, Carrie M Phillips, Andrew W Stadnyk, et al.
Scandinavian Journal of Immunology|March 17, 2009
Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordoniiM L Mayer, C M Phillips, R A Townsend, et al.
Journal of Diabetes and Its Complications|October 13, 2016
Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in miceFengming Liu, Rupam Sahoo, Xiaowen Ge, et al.
Molecular Medicine (Cambridge, Mass.)|November 1, 1996
The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranesJ A Acosta, L R Benzaquen, D J Goldstein, et al.
Pageof 55

Showing results (251-260 of 544) with videos related to

Sort By:
Pageof 55
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 2011
Optimizing Canadian public immunization programs: a prescription for actionDavid W Scheifele, Monika Naus, Natasha S Crowcroft, et al.
Vaccine|November 4, 2015
Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workersBrenda L Coleman, Shelly A McNeil, Joanne M Langley, et al.
Vaccine|December 17, 2005
Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of ageDavid W Scheifele, Scott A Halperin, Bruce Smith, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2020
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age NewbornsDongDong Ma, Miguel Angel Luque-Fernandez, Delia Bogdanet, et al.
The Pediatric Infectious Disease Journal|December 24, 2005
A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trialDavid W Scheifele, Scott A Halperin, Jan J Ochnio, et al.
The Pediatric Infectious Disease Journal|January 2, 2007
Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yetScott A Halperin, Wendy Vaudry, Francois D Boucher, et al.
Molecular Immunology|March 13, 2009
Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factorMatthew L Mayer, Carrie M Phillips, Andrew W Stadnyk, et al.
Scandinavian Journal of Immunology|March 17, 2009
Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordoniiM L Mayer, C M Phillips, R A Townsend, et al.
Journal of Diabetes and Its Complications|October 13, 2016
Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in miceFengming Liu, Rupam Sahoo, Xiaowen Ge, et al.
Molecular Medicine (Cambridge, Mass.)|November 1, 1996
The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranesJ A Acosta, L R Benzaquen, D J Goldstein, et al.
Pageof 55